MENU
CTXR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Citius Pharmaceuticals (CTXR) Earnings Date & Reports

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products... Show more

A.I. Advisor
published Earnings

CTXR is expected to report earnings to rise 20.59% to -40 cents per share on December 22

Citius Pharmaceuticals CTXR Stock Earnings Reports
Q3'26
Est.
$-0.41
Q2'26
Missed
by $0.37
Q1'26
Missed
by $0.75
Q3'25
Missed
by $0.51
Q2'25
Missed
by $0.85
The last earnings report on August 17 showed earnings per share of -34 cents, missing the estimate of 2 cents. With 20.71K shares outstanding, the current market capitalization sits at 14.96M.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry Biotechnology

Industry
Pharmaceuticals Major
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
23
Web
https://www.citiuspharma.com